SPIRO-QUINAZOLINONE DERIVATIVES USEFUL FOR THE TREATMENT OF NEUROLOGICAL DISEASES AND CONDITIONS
摘要
<p>The present invention relates to novel spiro-quinazolinone derivatives as positive allosteric modulators for modulating metabotropic glutamate receptor subtype 4 (mGluR4) and/or altering glutamate level or glutamatergic signalling</p>
申请公布号
CA2899957(A1)
申请公布日期
2014.08.07
申请号
CA20142899957
申请日期
2014.01.23
申请人
MERCK PATENT GMBH
发明人
BRUGGER, NADIA;HODOUS, BRIAN L.;SUTTON, AMANDA E.;POTNICK, JUSTIN;JOHNSON, THERESA L.;RICHARDSON, THOMAS E.;HAXELL, THOMAS FRANCIS NELSON;DORSEY, JAMES M.;FOGLESONG, ROBERT JAMES
